Head-to-head comparison
NAD+ vs Rapamycin
Physician-reviewed comparison
NAD+
Emerging ResearchLegal to Compound
A critical coenzyme involved in cellular energy production and DNA repair pathways.
Rapamycin
Peer ReviewedFDA Approved
An mTOR inhibitor FDA-approved as an immunosuppressant, now studied for longevity applications.
Quick Comparison
| Dimension | NAD+ | Rapamycin |
|---|---|---|
| Category | longevity | longevity |
| Classification | Nicotinamide Adenine Dinucleotide (Coenzyme) | mTOR Inhibitor (Macrolide) |
| Evidence Rating | Emerging Research | Peer Reviewed |
| Regulatory Status | Legal to Compound | FDA Approved |
| Delivery | Intravenous infusion, Subcutaneous injection, Oral supplement, Nasal spray | Oral tablet, Topical cream |
| Complexity | 4 / 5 | 4 / 5 |
| Refrigeration | Required | Not required |
Dosing Comparison
NAD+
Rapamycin
Longevity (Intermittent)
1–6 mg · weekly
Transplant Immunosuppression (FDA-Approved)
2–15 mg · daily
Can You Stack Them?
No known direct interaction between NAD+ and Rapamycin in our database. However, always consult your provider before combining compounds.
Medical Disclaimer
This comparison is for educational purposes only. Individual responses vary. Consult a qualified healthcare provider before using any compound.